Log in to save to my catalogue

Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, selectively decreas...

Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, selectively decreas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_21051353

Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

About this item

Full title

Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2007-07, Vol.104 (30), p.12518-12523

Language

English

Formats

More information

Scope and Contents

Contents

Alcohol dependence is a disease that impacts millions of individuals worldwide. There has been some progress with pharmacotherapy for alcohol-dependent individuals; however, there remains a critical need for the development of novel and additional therapeutic approaches. Alcohol and nicotine are commonly abused together, and there is evidence that...

Alternative Titles

Full title

Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_21051353

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_21051353

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

How to access this item